Nanoparticles of beetroot plant extract (Beta vulgaris L.) as an alternative therapy for type 1 diabetes mellitus : A review

Abstract

Type 1 diabetes mellitus is one of the most common degenerative diseases in the world. Out of 463 million diabetes mellitus patients in the world, 10% of them are type 1 diabetes mellitus patients. One of the complication causes and severity of type 1 diabetes mellitus is oxidative stress. Oxidative stress occurs due to the build-up of excess free radicals obtained from the metabolism of glucose and lipids. Free radicals that cause oxidative stress can be minimized with antioxidants. Beetroot (Beta vulgaris L.) is a plant that is rich in antioxidants and can be used as an alternative therapy for type 1 diabetes mellitus. Various flavonoid contents in beetroot extracts include quercetin, rutin, apigenin, kaempferol, and ferulic acid compounds that have antioxidant and antidiabetic activity. With the evolve of nanoparticle technology, it can be used to increase the solubility of drugs in water, to increase the duration of the drug in the systemic circulation, and to make drug release occurs gradually. The properties of this nanoparticle extract are indispensable for the efficacy and efficiency of treatment. The results of this study provide a lot of information and innovation for the development of the use of beetroot and the treatment of type 1 diabetes mellitus.